INNOVUS PHARMACEUTICALS, INC. Notes Payable, Current
INNOVUS PHARMACEUTICALS, INC. had Notes Payable, Current of $2.76 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2019-11-14
- 2019-09-30: Notes Payable, Current $2.76M.
- 2019-06-30: Notes Payable, Current $2.32M.
- 2019-03-31: Notes Payable, Current $2.23M.
- 2018-12-31: Notes Payable, Current $3.07M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2019-09-30 | $2.76M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.32M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $2.23M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.07M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $2.34M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.82M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.29M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.24M 10-K · filed 2019-04-01 | $1.24M 10-K · filed 2018-04-02 |
| 2017-09-30 | $722.47K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $819.25K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $802.05K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $626.61K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $274.54K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $333.75K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $320.47K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $73.20K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $119.07K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $359.92K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $305.91K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $314.02K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $242.49K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $480.95K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $435.20K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $370.00K 10-K · filed 2015-03-31 | |
| 2012-12-31 | $0.00 10-K/A · filed 2013-03-27 | |
| 2011-12-31 | $0.00 10-K/A · filed 2013-03-27 | |
| 2010-12-31 | $200.95K 10-K/A · filed 2013-03-27 | |
| 2009-12-31 | $379.86K 10-K/A · filed 2013-03-27 |